{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:50:47Z","timestamp":1790779847919,"version":"4.1.0"},"reference-count":6,"publisher":"JLE","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.nephro.2017.02.004","type":"journal-article","created":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T06:15:45Z","timestamp":1496297745000},"page":"S155-S156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"S1","title":["Syndromes hypertrophiques secondaires aux mutations de PIK3CA"],"prefix":"10.1684","volume":"13","author":[{"given":"Quitterie","family":"Venot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Canaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"18929","reference":[{"key":"10.1016\/j.nephro.2017.02.004_bib0035","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ajmg.a.36836","article-title":"PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation","volume":"167A","author":"Keppler-Noreuil","year":"2015","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.nephro.2017.02.004_bib0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/exd.12826","article-title":"Klippel-Trenaunay syndrome belongs to the PIK3CA-related overgrowth spectrum (PROS)","volume":"25","author":"Vahidnezhad","year":"2016","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.nephro.2017.02.004_bib0045","doi-asserted-by":"crossref","first-page":"e87623","DOI":"10.1172\/jci.insight.87623","article-title":"PIK3CA-associated developmental disorders exhibit distinct classes of mutations with variable expression and tissue distribution","volume":"1","author":"Mirzaa","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.nephro.2017.02.004_bib0050","series-title":"GeneReviews\u00ae","article-title":"PIK3CA-related segmental overgrowth","author":"Mirzaa","year":"1993"},{"key":"10.1016\/j.nephro.2017.02.004_bib0055","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1053\/j.sempedsurg.2014.07.003","article-title":"Management of visceral vascular anomalies","volume":"23","author":"Dasgupta","year":"2014","journal-title":"Semin Pediatr Surg"},{"key":"10.1016\/j.nephro.2017.02.004_bib0060","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/dth.12398","article-title":"Oral sildenafil as a treatment option for lymphatic malformations in PIK3CA-related tissue overgrowth syndromes","volume":"29","author":"Horbach","year":"2016","journal-title":"Dermatol Ther"}],"container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725517300457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725517300457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2017.02.004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:41:47Z","timestamp":1741192907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769725517300457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":6,"alternative-id":["S1769725517300457"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2017.02.004","relation":{},"ISSN":["1769-7255"],"issn-type":[{"value":"1769-7255","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Syndromes hypertrophiques secondaires aux mutations de PIK3CA","name":"articletitle","label":"Article Title"},{"value":"N\u00e9phrologie & Th\u00e9rapeutique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nephro.2017.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Soci\u00e9t\u00e9 francophone de n\u00e9phrologie, dialyse et transplantation. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}